Our study, taken together with these evidences, proposes that SIRT7 overexpression in cancer including HCC has important clinico-pathological implications, including value of SIRT7 as a prognostic and therapeutic candidate. The gene discussed is SIRT7; the disease is hepatocellular carcinoma.